QingSong Health Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	80.45	10.4	73.65	-2.06
Depreciation & Amortization	4.75	4.93	4.62	5.74
Other Amortization	0.05	0.05	0.05	0.03
Loss (Gain) From Sale of Assets	0	0.02	0	0.12
Loss (Gain) From Sale of Investments	50.09	50.26	44.8	145.63
Stock-Based Compensation	18.53	12.95	1.17	7.67
Provision & Write-off of Bad Debts	-0.14	0.04	0.29	0.2
Other Operating Activities	-79.02	-1.71	7.81	20.81
Change in Accounts Receivable	21.61	27.09	-67.62	-28.32
Change in Accounts Payable	-21.13	-8.29	35.53	-36.2
Change in Unearned Revenue	12.72	-15.73	-42.23	-83.09
Change in Other Net Operating Assets	2.42	4.07	-50.28	26.67
Operating Cash Flow	90.32	83.79	7.83	57.2
Operating Cash Flow Growth	57.90%	969.58%	-86.30%	-
Capital Expenditures	-0.61	-1.01	-0.18	-
Sale of Property, Plant & Equipment	0.01	-	-	0.14
Cash Acquisitions	-2.22	-2.22	-	-
Investment in Securities	-22.48	28.57	-108.19	-
Other Investing Activities	0.12	-8.81	103.48	-95.03
Investing Cash Flow	-25.19	16.53	-4.89	-94.9
Short-Term Debt Repaid	-	-26.08	-	-
Long-Term Debt Repaid	-	-4.54	-4.95	-4.99
Total Debt Repaid	-30.47	-30.62	-4.95	-4.99
Net Debt Issued (Repaid)	-30.47	-30.62	-4.95	-4.99
Financing Cash Flow	-104.82	-30.62	-4.95	-4.99
Foreign Exchange Rate Adjustments	-0.37	-0.34	-0.39	0.64
Net Cash Flow	-40.05	69.36	-2.39	-42.04
Free Cash Flow	89.71	82.79	7.65	57.2
Free Cash Flow Growth	56.83%	981.75%	-86.62%	-
Free Cash Flow Margin	7.20%	8.76%	1.56%	14.53%
Free Cash Flow Per Share	0.59	0.82	0.04	0.71
Cash Income Tax Paid	-	-	0.26	7.34
Levered Free Cash Flow	-	53.8	71.32	-
Unlevered Free Cash Flow	-	53.8	71.32	-
Change in Working Capital	15.62	7.14	-124.59	-120.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.